Nasdaq

ReWalk Announces Publication of ReStore Powered Exo-Suit Clinical Study Results

Primary Study End Points of Device Safety and Feasibility Received Positive Results; Majority of Participants Experienced Clinically Meaningful Walking Speed Improvements MARLBOROUGH, Mass., June 22, ...
WBJournal

Study: ReWalk soft exoskeleton improves walking speed in 64% of patients

A new study published in the Journal of NeuroEngineering and Rehabilitation indicates 64% of study participants who experienced stroke-related mobility issues were able to walk significantly faster ...

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the ...
Seeking Alpha

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving ...
Business Insider

ReWalk Robotics Donates ReStore Exo-Suit to Brooks Rehabilitation to Support Stroke Survivors

MARLBOROUGH, Mass., Dec. 21, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb ...
Seeking Alpha

Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (RWLK), (“ReWalk” or the “Company”), a leading provider of innovative technologies that ...
Nasdaq

ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 29, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals ...
Morningstar

FDA Issues Clearance for ReWalk 7 Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to ...
EurekAlert!

Researchers report positive results for ReWalk ReStore exosuit in stroke rehabilitation

East Hanover, NJ. September 9, 2020. A team of U.S. researchers published the results of a multi-center, single-arm trial of the ReWalk ReStore™ for gait training in individuals undergoing post-stroke ...
BioWorld

Rewalk's exosuit shown to 'Restore' ability of stroke patients to walk

An exosuit developed by Harvard University's Wyss Institute for Biologically Inspired Engineering has been shown to help facilitate normal walking ability for ambulatory patients following a stroke.
WBJournal

ReWalk exo-suit designated as breakthrough device by FDA

The U.S. Food & Drug Administration has granted breakthrough device designation for an exo-suit helping people with neurological-injury-related ankle issues walk, according to ReWalk Robotics, Ltd. of ...